Skip to search formSkip to main contentSkip to account menu

Advair Diskus

A dry powdered inhaler formulation of fluticasone-salmeterol drug combination.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background: Wixela™ Inhub™ is a fluticasone propionate/salmeterol dry powder inhaler developed as a generic equivalent of Advair… 
2019
2019
Background: Wixela® Inhub® is a dry powder inhaler approved as a generic equivalent to Advair® Diskus® (fluticasone propionate… 
2017
2017
We previously demonstrated pharmacokinetic differences among manufacturing batches of a US Food and Drug Administration (FDA… 
2017
2017
Rationale: OT329 SOLIS is a generic candidate for the branded asthma treatment, ADVAIR DISKUS (fluticasone propionate/salmeterol… 
Highly Cited
2011
Highly Cited
2011
The FDA has issued a requirement for manufacturers of long-acting beta-agonists (LABAs) marketed for asthma to conduct controlled… 
Review
2006
Review
2006
The LABAs have played an important role in the management of asthma over the past decade. They are of clear benefit in reducing… 
Highly Cited
2005
Highly Cited
2005
Context Although many Americans use the Internet to purchase drugs from Canadian pharmacies, no study has systematically… 
2004
2004
  • D. Bogen, A. Apter
  • The Journal of allergy and clinical immunology
  • 2004
  • Corpus ID: 44974864
2002
2002
BACKGROUND Options for step-down therapy include use of inhaled corticosteroids alone or in combination with a long-acting beta2… 
Review
2001
Review
2001
  • H. Nelson
  • The Journal of allergy and clinical immunology
  • 2001
  • Corpus ID: 26917213
Several classes of medications are available for the treatment of asthma, and often they must be taken concurrently to achieve…